Late Temporal Lobe Necrosis After Conventional Radiotherapy for Carcinoma of Maxillary Sinus
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Cerebral radiation necrosis is a serious late complication after conventional radiotherapy that can present with focal neurologic deficits or with more generalized signs and symptoms of increased intracranial pressure, depending on the location. The incidence and severity of radionecrosis are dose-volume dependent. We report a case of cerebral radiation necrosis 5 years after radiotherapy for a maxillary sinus carcinoma.
Citing Articles
Sharma M, Jensen K, Amidi A, Eskildsen S, Johansen J, Grau C Clin Transl Radiat Oncol. 2020; 25:52-60.
PMID: 33024844 PMC: 7530204. DOI: 10.1016/j.ctro.2020.09.003.
References
1.
Ruben J, Dally M, Bailey M, Smith R, McLean C, Fedele P
. Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. Int J Radiat Oncol Biol Phys. 2006; 65(2):499-508.
DOI: 10.1016/j.ijrobp.2005.12.002.
View
2.
WISOFF H, Llena J
. Glioblastoma multiforme of the cerebellum five decades after irradiation of a cerebellar tumor. J Neurooncol. 1989; 7(4):339-44.
DOI: 10.1007/BF02147091.
View
3.
Fontana M, Mastrostefano R, Bernabei A, Cianfrone G, Pompili A, TANFANI G
. Bilateral temporal lobectomy for late radionecrosis after radiotherapy for acromegaly. A case report. J Neurosurg Sci. 1984; 28(2):107-12.
View
4.
Minniti G, Traish D, Ashley S, Gonsalves A, Brada M
. Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab. 2004; 90(2):800-4.
DOI: 10.1210/jc.2004-1152.
View
5.
Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T
. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol. 2000; 21(5):901-9.
PMC: 7976740.
View